Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

The meeting discussed various skin conditions, treatments, and unusual cases, highlighting the effectiveness of tetracycline in treating rosacea.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Wnt5a may contribute to psoriasis by reducing skin cell growth, blocking skin cell maturation, and increasing inflammation.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Anti-TNF therapy can cause hair loss and skin issues.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Some drugs used to treat inflammation may cause hair loss.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The document concludes that diagnosing and managing plaque psoriasis, particularly in sensitive areas, is challenging and requires careful differentiation from similar skin conditions.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Certain human skin cells marked by CD44 and ALDH are rich in stem cells capable of long-term skin renewal.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.